|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 482.90 USD | -0.64% |
|
-2.11% | +7.21% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 27.8x | 5.57x | 1.97x | 8.4x | 18.93x | 19.84x | -.--% | 123B | ||
| 34.75x | 20.82x | 0.75x | 12.42x | 25.87x | 26.87x | 0.58% | 1,043B | ||
| 26.86x | 6.72x | -1.72x | 6.13x | 16.78x | 18.44x | 2.15% | 602B | ||
| 33.14x | 12662.52x | 0.15x | 7.52x | 15.43x | 15.94x | 2.7% | 449B | ||
| 17.71x | 6.56x | 1.06x | 4.39x | 10.82x | 12.17x | 3.02% | 327B | ||
| 21.31x | 6.14x | -28.59x | 5.47x | 13.24x | 14.48x | 2.89% | 279B | ||
| 21.26x | 4.98x | 0.95x | 4.48x | 12.39x | 13.4x | 1.96% | 264B | ||
| 24.37x | 18.75x | 3.41x | 6.42x | 11.35x | 14.71x | 2.71% | 201B | ||
| -49.1x | 8.6x | 0.35x | 5.86x | 32.41x | 64.88x | 2.38% | 169B | ||
| 12.77x | 1.63x | 0.29x | 3.12x | 7.88x | 8.91x | 6.86% | 143B | ||
| 11.75x | 5.31x | 0.24x | 3.22x | 8.67x | 9.32x | 4.16% | 124B | ||
| 11.61x | 1.23x | 3.28x | 2.17x | 6.97x | 7.93x | 5.53% | 106B | ||
| 12.39x | 4.51x | 1.04x | 2.75x | 7.94x | 9.1x | 3.56% | 105B | ||
| 23.41x | 5.31x | 1.36x | 7.92x | 14.97x | 15.67x | 1.89% | 73.36B | ||
| 40.1x | 5.4x | 2.19x | 9.09x | 30.06x | 31.16x | 0.48% | 54.49B | ||
| 20.63x | 1.67x | -0.13x | 1.73x | 8.19x | 13.75x | 0.48% | 53.63B | ||
| 43.01x | 1.15x | 23.09x | 2.66x | 9.41x | 26.91x | 3.82% | 51.98B | ||
| 19.11x | 1.93x | 4.08x | 3.47x | 13.01x | 14.6x | 2.16% | 43.95B | ||
| 37.39x | 17.78x | 0.17x | 6.23x | 28.31x | 27.37x | -.--% | 37.8B | ||
| Average | 20.54x | 672.98x | 0.73x | 5.44x | 15.40x | 19.23x | 2.49% | 223.68B | |
| Weighted average by Cap. | 23.52x | 1,348.55x | -1.05x | 7.19x | 17.34x | 20.02x | 2.19% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















